期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤标志物对乳腺癌预后的评估

The prognostic significance of tumor markers for breast cancer
下载PDF
导出
摘要 目的寻找更好的乳腺癌肿瘤标志物。方法分析了几种肿瘤标志物对乳腺癌预后的评估。结果肿瘤标志物对乳腺癌预后的评估有重要的意义。结论在判断预后时,肿瘤标志物会提供很多信息。 Objective:To search the better tumor markers for breast cancer.Methods:Analyse the prognostic significance of the several tumor markers for breast cancer.Results:The prognostic significance of tumor markers for breast cancer is valuable.Conclusion:When the judgment prognosis,the tumor markers can provide a lot of informations.
作者 朱涛 郑巧敏 董敏
机构地区 温州医学院
出处 《井冈山医专学报》 2004年第3期16-18,共3页 Journal of Jinggangshan Medical College
关键词 肿瘤标志物 乳腺癌 预后 tumor marker breast cancer prognosis
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献18

  • 1[1]Fiebiger W, Wiltschke C. Tumor markers[J] .Acta Med Austriaca, 2001, 28(2): 33-37.
  • 2[2]Rossi Fanelli F, Cangiano C, Muscaritoli M, et al. Tumor induced changes in host metabolism: a possible marker of neoplastic disease[J] .Nutrition, 1995, 11(5 Suppl):595-600.
  • 3[3]Kondo H, Nobuoka A. Clinical application of oncogene and antioncogene as a tumor marker[J]. Nippon Rinsho, 1996,54(6): 1494-1498.
  • 4[4]Massidda B, Ionta MT. usefulness of pyridinium crosslinks and CA153 as markers in metastatic bone brest carcionoma[J]. Anticancer Res, 1996, 16(4): 2221-2229.
  • 5[6]Duffy MJ. Proteases as prognostic markers in cancer[J]Clin cancer Res, 1996,2(4): 613-618.
  • 6[7]Foekens JA, Peters HA, Grebenchtchikov N, et al. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer[J]. Cancer Res, 2001,61(14): 5407-5414.
  • 7[8]Kinoshita J, kitamura K, et al. Clinical significance of vascular endothelial growth factor-c(VEGF-C) in breast cancer[J]. Breast Cancer Res Treat, 2001, 66(2): 159-164.
  • 8[9]Bjorklund B, Einarsson R. Serum tissue polypeptide specific antigen in oncologic practice: a review with reference to 3000 cases of breast cancer[J]. Tumor Diagn Ther, 1996,17(1): 67-72.
  • 9陈燕,杨建伟,李建成,黄建英,胡敏华.TPS对转移性乳腺癌的临床应用价值[J].中国肿瘤临床与康复,2001,8(2):55-57. 被引量：16
  • 10郑航,何本夫,罗荣城,尤长宣,麦国丰,卢惠芳.组织多肽特异性抗原在乳腺癌中的临床研究[J].第一军医大学学报,2003,23(8):823-825. 被引量：6

二级参考文献19

  • 1[1]Bjorklund B,Einarsson R.TPS(tissue polypeptide specific antigen)in onc ologic practice:A review with reference to 3000 cases of breast cancer[J].Tumo r diagnther,1996;17(3):67.
  • 2[2]Giai M,Roagna R,Ponzone R et al.TPS and CA15-3 serum values as a guid e for treating and monitoring breast cancer patients[J].Anticancer Research, 1996;16(2):875.
  • 3[3]Schuurman JJ,Bong SB,Einarsson R.Determination of serum tumor mark ers TPS and CA15-3 in breast cancer patients [J].AnticancerRes,1996;16:2169.
  • 4[4]Barak V,Nisman B,Roisman I,et al.TPS in assessing response to ther apy and prognosis of breast cancer patietns treated with interferons[J].J Tumor Ma rkerOncol,1997;12:17.
  • 5[5]Rydlander L,Ziegler E,Bergman T,et al.Molecular characterization o f a t issue polypeptide-specific-antigen epitope and its relationship to human cytok eration 18[J].Eur JBiochem,1996;241:309.
  • 6[6]Haywoardt JL,Carbone PP,Heuson J-C et al.Assessment of response t o therapy in advanced breast cancer[J].Eur Jcancer,1997;13:89.
  • 7[7]Klein B,lurie H,levin I et al A comparative study of tumor markers of proliferation differentiation and tumor immunology in breast cancer patients[J ].Cancer J,1994;7:238.
  • 8[8]Aydiner A,Topusz E,Disci R,et al.Serum tumor markers for detection of bone metastasis in breast cancer patients[J].ActaOncol,1994;33:181.
  • 9[9]Blijlevens N M A,Oosterhuis W P,Oosten H R,et al.Clinical value of TPS ,CEA and CA15-3 in breast cancer patients[J].AnticancerRes,1995;15:2711.
  • 10[10]Kopczynski Z,Thielemann A.The value of tissue polypeptide specifi c an tigen TPS determination in serum of women with breast cancer comparison to mucin like associated antigen MCA and CA15-3 antigen[J].Eur J Gynaecol Oncol,1998;19:503.

共引文献28

井冈山医专学报
2004年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部